共 7 条
[1]
Structure–activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2;4-dione: Development of potential substrate-specific ERK1/2 inhibitors.[J].Qianbin Li;Adnan Al-Ayoubi;Tailiang Guo;Hui Zheng;Aurijit Sarkar;Tri Nguyen;Scott T. Eblen;Steven Grant;Glen E. Kellogg;Shijun Zhang.Bioorganic & Medicinal Chemistry Letters.2009, 21
[2]
Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury
[J].
BIOCHEMICAL PHARMACOLOGY,
2009, 77 (12)
:1827-1834
Schuh, Katrin
;
Pahl, Andreas
.
[3]
Molecular modeling and crystal structure of ERK2–hypothemycin complexes.[J].Giulio Rastelli;Robin Rosenfeld;Ralph Reid;Daniel V. Santi.Journal of Structural Biology.2008, 1
[4]
FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice
[J].
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY,
2007, 374 (04)
:311-316
Ohori, Makoto
;
Takeuchi, Mikio
;
Maruki, Riyo
;
Nakajima, Hidenori
;
Miyake, Hiroshi
.
[5]
Functions of the MAPK family in vertebrate-development
[J].
FEBS LETTERS,
2006, 580 (21)
:4984-4990
Krens, S. F. Gabby
;
Spaink, Herman P.
;
Snaar-Jagalska, B. Ewa
.
[6]
Identification of a selective ERK inhibitor and structural determination of the inhibitor–ERK2 complex.[J].Makoto Ohori;Takayoshi Kinoshita;Mitsuru Okubo;Kentaro Sato;Akiko Yamazaki;Hiroyuki Arakawa;Shintaro Nishimura;Noriaki Inamura;Hidenori Nakajima;Masahiro Neya;Hiroshi Miyake;Takashi Fujii.Biochemical and Biophysical Research Communications.2005, 1
[7]
Inhibition of HgCl2-induced mitogen-activated protein kinase activation by LL-Z1640-2 in CCRF-CEM cells
[J].
EUROPEAN JOURNAL OF PHARMACOLOGY,
2000, 409 (02)
:155-158
Matsuoka, M
;
Wispriyono, B
;
Iryo, Y
;
Igisu, H
;
Sugiura, T
.